Efficacy and anti-inflammation activity of a selective phosphodiesterase-4 inhibitor cilomilast in treatment of COPD

被引：0
|
作者：
Wang, CZ [1 ]
Song, YX [1 ]
Liao, XQ [1 ]
Li, Q [1 ]
Wang, JP [1 ]
Zhao, ZQ [1 ]
机构：
[1] Xinqiao Hosp, Chongqing, Peoples R China
来源：
CHEST | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：262S / 262S
页数：1
相关论文
共 50 条
  • [1] Cilomilast: Orally active selective phosphodiesterase-4 inhibitor for treatment of chronic obstructive pulmonary disease
    Martina, Shaunta' D.
    Ismail, Maha S.
    Vesta, Kimi S.
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (10) : 1822 - 1828
  • [2] Roflumilast, a phosphodiesterase-4 inhibitor, improves hyperoxia-induced lung injury via anti-inflammation
    Cao, Hong-Ying
    Yu, Tian-Hua
    Han, Cui-Hong
    Liu, Wen-Wu
    Zhang, Pei-Xi
    Tang, Peng
    UNDERSEA AND HYPERBARIC MEDICINE, 2020, 47 (02) : 189 - 196
  • [3] Bioavailability of the oral selective phosphodiesterase 4 inhibitor cilomilast
    Zussman, BD
    Davie, CC
    Kelly, J
    Murdoch, RD
    Clark, DJ
    Schofield, JP
    Walls, C
    Birrell, C
    Webber, D
    Quinlan, J
    Ritchie, SY
    Carr, A
    PHARMACOTHERAPY, 2001, 21 (06): : 653 - 660
  • [4] Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study
    Compton, CH
    Gubb, J
    Nieman, R
    Edelson, J
    Amit, O
    Bakst, A
    Ayres, JG
    Creemers, JPHM
    Schultze-Werninghaus, G
    Brambilla, C
    Barnes, NC
    LANCET, 2001, 358 (9278): : 265 - 270
  • [5] Phosphodiesterase-4 inhibitors as a novel approach for the treatment of respiratory disease: cilomilast
    Kroegel, Claus
    Foerster, Martin
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (01) : 109 - 124
  • [6] Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patients
    Porpodis, Konstantinos
    Domvri, Kalliopi
    Zarogoulidis, Paul
    Petridis, Dimitrios
    Tsirgogianni, Katerina
    Papaioannou, Antonis
    Hatzizisi, Olga
    Kioumis, Ioannis
    Liaka, Alexandra
    Kikidaki, Violeta
    Lampaki, Sofia
    Organtzis, John
    Zarogoulidis, Konstantinos
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 1123 - 1128
  • [7] Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease
    Gamble, E
    Grootendorst, DC
    Brightling, CE
    Troy, S
    Qiu, YS
    Zhu, J
    Parker, D
    Matin, D
    Majumdar, S
    Vignola, AM
    Krogel, C
    Morell, F
    Hansel, TT
    Rennard, SI
    Compton, C
    Amit, O
    Tat, T
    Edelson, J
    Pavord, ID
    Rabe, KF
    Barnes, NC
    Jeffery, PK
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (08) : 976 - 982
  • [8] Experience of application the selective phosphodiesterase-4 inhibitor roflumilast in the patient with COPD and the metabolic syndrome
    Blinova, Elena
    Ignatova, Galina
    Belsner, Maria
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [9] Lack of clinical efficacy of a phosphodiesterase-4 inhibitor for treatment of heaves in horses
    Lavoie, JP
    Pasloske, K
    Joubert, P
    Cordeau, ME
    Mancini, J
    Girard, Y
    Friesen, RW
    Frenette, R
    Blouin, M
    Young, RN
    Hickey, G
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2006, 20 (01): : 175 - 181
  • [10] Selective phosphodiesterase-4 (PDE-4) inhibitors in COPD
    Tatlicioglu, Turkan
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2008, 56 (04): : 472 - 484
12345